Sequential single-agent chemotherapy for metastatic breast cancer: Therapeutic nihilism or realism?

被引：18

作者：

Seidman, AD ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2003年 / 21卷 / 04期

关键词：

D O I：

10.1200/JCO.2003.10.086

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：577 / 579

页数：3

相关论文

共 24 条

[1]

Abe O, 1998, LANCET, V352, P930

[2]

[Anonymous], P AM SOC CLIN ONCOL

[3]

[Anonymous], 2002, P AM SOC CLIN ONCOL

[4]

[Anonymous], 1999, P AM SOC CLIN ONCOL

[5] Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: Final results of a phase III study with a factorial design [J].

Berruti, A ;

Bitossi, R ;

Gorzegno, G ;

Bottini, A ;

Alquati, P ;

De Matteis, A ;

Nuzzo, F ;

Giardina, G ;

Danese, S ;

De Lena, M ;

Lorusso, V ;

Farris, A ;

Sarobba, MG ;

DeFabiani, E ;

Bonazzi, G ;

Castiglione, F ;

Bumma, C ;

Moro, G ;

Bruzzi, P ;

Dogliotti, L .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) :4150-4159

[6] Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 multicenter phase III trial [J].

Biganzoli, L ;

Cufer, T ;

Bruning, P ;

Coleman, R ;

Duchateau, L ;

Calvert, AH ;

Gamucci, T ;

Twelves, C ;

Fargeot, P ;

Epelbaum, R ;

Lohrisch, C ;

Piccart, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (14) :3114-3121

[7] Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer [J].

Bishop, JF ;

Dewar, J ;

Toner, GC ;

Smith, J ;

Tattersall, MHN ;

Olver, IN ;

Ackland, S ;

Kennedy, I ;

Goldstein, D ;

Gurney, H ;

Walpole, E ;

Levi, J ;

Stephenson, J ;

Canetta, R .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2355-2364

[8]

BONNETERRE J, 2001, P AN M AM SOC CLIN, V20, pA42

[9]

CARMICHAEL J, 2001, P AN M AM SOC CLIN, V20, pA22

[10]

Citron M, 2002, BREAST CANCER RES TR, V76, pS32